Skip to content

BBNX BBNX Financing Cash Flow

Financing Cash Flow at other companies

Insulet logo
InsuletPODD
-$319.9M-215%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$274.16M+5,948%
Medtronic logo
MedtronicMDT
-$888M+33.9%
AdaptHealth logo
AdaptHealthAHCO
$52.56M+194%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
-$1.61M+51.4%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's financing cash flow?
BBNX (BBNX) reported financing cash flow of $623K in Q1 2026.
How has BBNX's financing cash flow changed year-over-year?
BBNX's financing cash flow decreased by 99.7% year-over-year, from $211.12M to $623K.
What is the long-term trend for BBNX's financing cash flow?
Over 2 years (2023 to 2025), BBNX's financing cash flow has grown at a 45.8% compound annual growth rate (CAGR), from $101.03M to $214.87M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.